medicine-technology-1/hologic-announces-fourth-quarter-and-fiscal-2009-operating-results-6111-19/;+health+history;+medical+history.html

Navigation LinksBiology News Health News Biology Technology Medicine Technology

Biology News Medicine News Biology Products Medicine Products Biology Definition Medicine Definition Biology Technology Medicine Technology Biology Dictionary Medicine Dictionary

We're sorry, that page (http://www.bio-medicine.org/medicine-technology-1/hologic-announces-fourth-quarter-and-fiscal-2009-operating-results-6111-19/;+health+history;+medical+history.html) was not found.

Search medicine technology 1 hologic announces fourth quarter and fiscal 2009 operating results 6111 19 ;+health+history;+medical+history html at Google

Search medicine technology 1 hologic announces fourth quarter and fiscal 2009 operating results 6111 19 ;+health+history;+medical+history html at Yahoo

Search medicine technology 1 hologic announces fourth quarter and fiscal 2009 operating results 6111 19 ;+health+history;+medical+history html at Msn

Breaking Biology News(10 mins):BIO-key(R) Shareholders Overwhelmingly Approve Sale of Law Enforcement Division 2 BIO-key(R) Shareholders Overwhelmingly Approve Sale of Law Enforcement Division 3 AGU fall meeting: Preliminary press conference topics, press pre-registration deadline 2 AGU fall meeting: Preliminary press conference topics, press pre-registration deadline 3 AGU fall meeting: Preliminary press conference topics, press pre-registration deadline 4 AGU fall meeting: Preliminary press conference topics, press pre-registration deadline 5 AGU fall meeting: Preliminary press conference topics, press pre-registration deadline 6 Time to Blow Up the Pharmaceutical Sales Model 3F New Deloitte Debate 6403 1 Time to Blow Up the Pharmaceutical Sales Model 3F New Deloitte Debate 6403 2 Time to Blow Up the Pharmaceutical Sales Model 3F New Deloitte Debate 6403 3 Curemark Opens Patient Enrollment for Autism Treatment at Three More Clinical Trial Sites 6401 1 Curemark Opens Patient Enrollment for Autism Treatment at Three More Clinical Trial Sites 6401 2 Curemark Opens Patient Enrollment for Autism Treatment at Three More Clinical Trial Sites 6401 3 Perrigo Company To Present at the Sidoti Emerging Growth Conference 6399 1

[1] BIO-key(R) Shareholders Overwhelmingly Approve Sale of Law Enforcement Division [0] AGU fall meeting: Preliminary press conference topics, press pre-registration deadline [0] Love hurts: Why emotional pain really affects us

Breaking Medicine News(10 mins):Health News:Mercy Primary Care Center Receives $15,000 in Matching Grants for Diabetes Management Program, 2 Health News:Mercy Primary Care Center Receives $15,000 in Matching Grants for Diabetes Management Program, 3 Health News:Highmark Inc. Employees Earn $7,000 for Nonprofit Organizations 2 Health News:PA Registered Nurses Can Earn Continuing Education Hours Through Pennsylvania Patient Safety Advisories 2 Health News:Controversial kidney transplant technique could provide lifeline for very ill patients 2 Health News:Kroll Fraud Solutions to Host Webinar for Healthcare Organizations on Achieving HITECH Compliance 2 Health News:Kroll Fraud Solutions to Host Webinar for Healthcare Organizations on Achieving HITECH Compliance 3

[0] Mercy Primary Care Center Receives $15,000 in Matching Grants for Diabetes Management Program,[0] Highmark Inc. Employees Earn $7,000 for Nonprofit Organizations [0] PA Registered Nurses Can Earn Continuing Education Hours Through Pennsylvania Patient Safety Advisories [0] Controversial kidney transplant technique could provide lifeline for very ill patients [0] Kroll Fraud Solutions to Host Webinar for Healthcare Organizations on Achieving HITECH Compliance

Biology Products:

Phosphate-Buffered Saline (PBS) 7.4 (1X) liquid SuperCase from Invitrogen McCoy's 5A Medium (Modified) (Custom) from Invitrogen LB Broth Base powder (Lennox L Broth Base) from Invitrogen Rabbit Anti-Human Connexin 36 Monoclonal Antibody, Clone ZMD.257 from Invitrogen

Medicine Products:

Solo Lumbar Allograft System VG2 PLIF Allograft Graftech Posterior Ramp Metrx System

Breaking Biology Technology:Vivakor Confirms Record Date of Stock Dividend 2 Vivakor Confirms Record Date of Stock Dividend 3 Nikon Corporation Acquires License From Harvard University For 'STORM' Super Resolution Microscopy -- Will Create Innovative New 'N-STORM' Microscope 2 Nikon Corporation Acquires License From Harvard University For 'STORM' Super Resolution Microscopy -- Will Create Innovative New 'N-STORM' Microscope 3 Reportlinker Adds Neurostimulation - A Global Market Perspective 2 Reportlinker Adds Neurostimulation - A Global Market Perspective 3 Reportlinker Adds Neurostimulation - A Global Market Perspective 4 Reportlinker Adds Neurostimulation - A Global Market Perspective 5 Reportlinker Adds Neurostimulation - A Global Market Perspective 6

[0] Vivakor Confirms Record Date of Stock Dividend [0] Nikon Corporation Acquires License From Harvard University For 'STORM' Super Resolution Microscopy -- Will Create Innovative New 'N-STORM' Microscope [0] Inverness Medical Innovations Declares Dividend on its Series B Convertible Perpetual Preferred Stock [0] Reportlinker Adds Neurostimulation - A Global Market Perspective

Breaking Medicine Technology:Amgen Board Authorizes $5 Billion Increase in Stock Repurchase Program 2 Amgen Board Authorizes $5 Billion Increase in Stock Repurchase Program 3 Genoptix Announces Participation at Deutsche Bank 2009 MedTools Investor Conference 2 Successful Phase I/II Clinical Trial for BiondVax Pharmaceuticals' Universal Flu Vaccine 2 Successful Phase I/II Clinical Trial for BiondVax Pharmaceuticals' Universal Flu Vaccine 3 Successful Phase I/II Clinical Trial for BiondVax Pharmaceuticals' Universal Flu Vaccine 4 Successful Phase I/II Clinical Trial for BiondVax Pharmaceuticals' Universal Flu Vaccine 5 Multidisciplinary meeting on urological cancers aims to benefit cancer patients 61702 1 Multidisciplinary meeting on urological cancers aims to benefit cancer patients 61702 2 Is type 2 diabetes mellitus a risk factor for gallbladder biliary and pancreatic cancer 3F 61700 1 Pivotal study for PSD502 the first potential treatment for premature ejaculation 61698 1 Pivotal study for PSD502 the first potential treatment for premature ejaculation 61698 2 Pivotal study for PSD502 the first potential treatment for premature ejaculation 61698 3

[0] Amgen Board Authorizes $5 Billion Increase in Stock Repurchase Program [0] Genoptix Announces Participation at Deutsche Bank 2009 MedTools Investor Conference [0] Successful Phase I/II Clinical Trial for BiondVax Pharmaceuticals' Universal Flu Vaccine